SCHEMBL15072202

SCHEMBL15072202

O=C(O)c1cn(-c2ccncc2)nc1-c1ccccc1F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.65
KDM4E B2RXH2 7/20 0.65
L3MBTL1 Q9Y468 4/20 0.65
HPGD P15428 4/20 0.65
HSD17B10 Q99714 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
MAPT P10636 4/20 0.49
LMNA P02545 2/20 0.49
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 3/20 0.46
MAPK1 P28482 1/20 0.46
PTGS2 P35354 1/20 0.42
ACMSD Q8TDX5 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15072199 0.84 ALDH1A1 (0.65) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15072190 0.84 ALDH1A1 (0.65) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15072194 0.84 ALDH1A1 (0.65) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15076914 0.82 ALDH1A1 (0.89) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL6681044 0.79 ALDH1A1 (1.00) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15070383 0.79 ALDH1A1 (0.88) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15072191 0.78 ALDH1A1 (0.72) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15070207 0.77 ALDH1A1 (0.67) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL15072197 0.77 ALDH1A1 (0.66) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10
SCHEMBL21854134 0.76 LMNA (0.44) ALDH1A1KDM4ESMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013096630-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 WO disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165464-A1 HETEROARYLS AND USES THEREOF PIK3C2B, PI4KB, PIK3R4 ALDH1A1 2884/4885KDM4E 1614/4885L3MBTL1 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.